FDA Approves Self-Collection Screening For Cervical Cancer

May 16, 2024
Image

It’s to reach women who traditionally haven’t been reached.

Jeff Andrews, vice president of medical and scientific affairs at BD, a maker of the new self-tests for cervical cancer screening. The tests should be available this summer.

Why It Matters: For the first time ever, women will be able to self-screen for HPV – the virus causing the majority of cervical cancers. Doctors typically test for HPV using pelvic exams, but patients opting for self-testing will have the option to collect their own sample with a swab while in a health care setting (such as pharmacies, mobile clinics or a doctor’s office). According to the World Health Organization, cervical cancer is the fourth most common form of cancer among women across the globe. Professionals hope the new self-collection option will help increase access to screening and enable quicker prevention when precancerous or cancerous cells are discovered sooner.

Read More: FDA approves self-tests for cervical cancer, as an alternative to the dreaded pelvic exam (USA Today)

by Emily Hooker, based in Texas

ImageImageImageImage